This page shows anti-doping rule violation data we have registered for Continuous Erythropoeitin Receptor Activators.
Continuous Erythropoeitin Receptor Activators ranks #55 globally among prohibited substances, with 60 registered cases (0.4% of all violations) among all sports tracked by the Anti-Doping Database, which contains 14,670 verified cases. Costa Rica leads with 11 cases, while Cycling is the most affected sport (41 cases).
Cycling has the most recorded cases of Continuous Erythropoeitin Receptor Activators violations globally, with 41 registered cases — 0% of all 60 verified cases.
Costa Rica leads in Continuous Erythropoeitin Receptor Activators violations globally, with 11 registered cases — 18.3% of all 60 verified cases.
Continuous Erythropoeitin Receptor Activators ranks #55 of 358 prohibited substances in the Anti-Doping Database.
This ranking covers only prohibited substances with verified case records in the Anti-Doping Database. Procedural violations (whereabouts failures, refusals to test, etc.) are excluded.
The average suspension for Continuous Erythropoeitin Receptor Activators violations is 42.4 months, longer than the global average of 30.1 months.
If you use this data, please credit The Anti-Doping Database
Used by journalists, sport lawyers, NADOs and researchers worldwide for proactive strategy — not just post-case research.
As a subscriber you get instant access to verified, structured anti-doping case data — from hours of research to seconds:
The Anti-Doping Database currently contains 14,670 verified anti-doping rule violations across all sports and all countries, and is updated regularly.